Baxter Biopharma Solutions will invest $100 million to expand its fill-finish capabilities at a plant in Halle/Westfalen, Germany. The German facility is operated by Baxter Biopharma Solutions (BPS), the contract development manufacturing organization (CDMO) arm of Baxter International. The $100 million expansion will add a syringe filling line and additional lyophilized and liquid vial capacity. According to the firm, the addition of an aseptic syringe filling line will enable BPS to meet the increased demand for fill-finish services in Europe…

Pall will hire 300 people to staff its single-use bioprocessing manufacturing facility in Duncan, South Carolina. Cytiva and Pall announced a $1.5 billion investment in July (in addition to Cytiva’s $500 million growth strategy that was announced in September 2020 and January) to expand manufacturing capacity for life sciences products at thirteen Danaher Corporation sites to meet customer demand. Part of this investment includes the construction of facilities in the US and the UK over the next two years. Now Pall is…

Having ditched a manufacturing plant in Maryland, Autolus Therapeutics has broken ground on a facility in the UK, which – alongside $250 million in investment from Blackstone – aims to support CAR-T candidate obe-cel. The 70,000 square-foot building in Stevenage, UK – close to the UK’s CGT Catapult with whom Autolus has an ongoing collaboration – is being built by construction specialist Merit and is set to support Autolus’s lead candidate obe-cel (obecabtagene autoleucel). The chimeric antigen receptor (CAR) T-cell…

Lykan Bioscience will expand its plant in Hopkinton, Massachusetts to support the growing demand for cell therapy development and production. Lykan Bioscience, a contract development manufacturing organization (CDMO) focused on cell-based therapies, will add seven cleanrooms with capabilities for autologous and allogenic production at its Hopkinton plant. “The demand in the cell therapy segment is robust, we brought the original 8 cGMP suites online in January of this year and we believe the original capacity will be fully allocated to…

Amgen has broken ground on its $365 million plant in New Albany, Ohio, which will support assembly and packaging for its medicines. Amgen announced its plans to build a 270,000 square-foot facility in New Albany in June, which would see the firm create approximately 400 jobs ranging from technicians, engineers, quality assurance, quality control, administrative and management positions. Now, the firm has started constructing the plant and says it expects the site to be fully operational by 2024. According to…

CDMO Samsung Biologics is preparing to construct a fifth biomanufacturing facility after acquiring 10,000 m2 of land in Songdo, Korea. In 2020, Samsung Biologics laid plans for a fourth ‘super plant’ at its site in Songdo, Incheon at a cost of over 2 trillion Korean won—roughly equivalent to $2 billion. Construction of the facility, which will house 256,000 liters of mammalian production capacity, is underway but in the meantime the contract development and manufacturing organization (CDMO) has made a move…

Bionova’s 2,000 L scale facility in Fremont, California marks a full transition to a contract development and manufacturing organization (CDMO) for the bioservices firm. In July 2020, Bionova broke ground on the $25 million Fremont facility with an aim to expand its protein, cell line, and process development services into the clinical and commercial manufacturing space. Fifteen months on and the company has officially opened the plant with the first clinical supply run expected to be completed before the end…

According to a report, almost half (44%) of mammalian biomanufacturing capacity will be controlled by contract manufacturers or hybrid firms by 2025, a jump from 32% in 2020. The paper entitled ‘Supply and Demand Trends: Mammalian Biomanufacturing Industry Overview,’ produced by BioProcess Technology Group BDO, forms part of the CPhI Pharma Annual Report, published ahead of next week’s event in Milan, Italy. The authors Dawn Ecker and Patricia Seymour claim that the projected kilogram quantities of product needed to meet…